Background Platelet activation plays a pivotal role in the pathogenesis of acute coronary disease. Monocytes are involved in the progression of atherosclerosis and are potent activators of blood coagulation through their ability to synthesize tissue factor (TF). The aim of this study was to compare markers of monocyte and coagulation activation in the systemic blood of patients with unstable angina, acute myocardial infarction, or stable angina.
Methods and Results
We studied 26 patients with unstable angina (10±5 hours after the onset of the last episode of pain), 18 patients with acute myocardial infarction (5+4 hours after the onset of pain), and 34 patients with stable angina. We measured levels of TF expression in peripheral blood mononuclear cells (isolated by gradient centrifugation and incubated for 16 hours, with or without endotoxin stimulation), levels of plasma prothrombin fragment 1+2 (Fl +2), and levels of fibrinogen in peripheral blood. In patients with unstable angina, both stimulated and unstimulated cells exhibited higher levels of TF expression than in patients with stable angina (P=.0001). In patients with acute myocardial infarction, monocyte TF activity did not differ from that in patients with stable angina. Mean levels of Fl +2 and of fibrinogen did not differ significantly between groups.
Although platelet activation has been demonstrated to play a major role in the pathogenesis of acute coronary syndromes,1-4 the more recent demonstration that granulocyte and monocyte activation occurs in unstable angina suggests that an inflammatory reaction may also contribute to the pathophysiology of these conditions.56 The involvement of various cell types, including blood leukocytes, in thrombosis and inflammation has been demonstrated through recent experimental and clinical studies. 78 In the vasculature, activated monocytes are potent activators of coagulation, through the expression of tissue factor (TF). TF is a high-affinity receptor and cofactor for factor ViI/VVla, and thus the cell surface molecule that initiates the extrinsic pathway of coagulation.9 Its expres-Only in the unstable angina group, a modest correlation was found between fibrinogen (r=.72, P=.005) and Fl+2 levels (r=.54, P=.001) levels and the degree of monocyte TF expression. In patients with unstable angina, monocyte TF expression (both stimulated and unstimulated, assessed by biological activity and by antigen techniques) and fibrinogen levels were correlated with the time elapsed from the beginning of the most recent episode of pain (.61 <r<.72, .02<P<.0001). By contrast, there was no correlation between these variables and the time from onset of pain in patients with acute myocardial infarction.
Conclusions A time-dependent activation of systemic monocytes and a time-dependent increase in fibrinogen levels occurs in unstable angina but not in myocardial infarction. These findings provide further evidence that a specific inflammatory process occurs in unstable angina. Further studies are required to determine whether monocyte activation is a cause or a consequence of plaque instability in patients with unstable angina and to clarify the interrelations between platelet and monocyte activation in these circumstances. (Circulation. 1994; 90:1662-1668.)
Key Words * monocytes * tissue factor * angina * myocardial infarction sion by monocytes is regulated by various immune and inflammatory stimuli such as bacterial lipopolysaccharides (LPS), lipoproteins, tumor necrosis factor, and T-helper lymphocyte activation.8 Whether increased monocyte TF expression is specific for unstable angina or also occurs in other acute coronary syndromes remains unclear. Additionally, the exact nature of the relation between monocyte activation and the activation of the coagulation system is not well understood.
The aim of this study was to prospectively compare TF expression in blood peripheral monocytes and a marker of activation of the coagulation system, prothrombin fragments 1 and 2 (F1+2), in patients with unstable angina, patients with myocardial infarction, and patients with stable exertional angina.10.11 
Results

Baseline Characteristics
There were no significant between-group differences in mean age or in the ratio of men to women ( Immunocstochenicail staining conifirmed the monocs.tic origin of the TF-activits (Fig 1) . Thc quaintitaitiec data are presented in Table 2 and Fig 2. Monocste TF activits and levels of TF antigen did not differ significaiitlx between patients with stable angina and those with mrocardial infarction. In contrast, patients w ith unstable angina show ed at mnarked increase in monoecyte TF expression after incubation with or without endotoxin stimulation. as compared w-ith the groups with effort angina or w-ith mvocardial infarctioin (P-.011)1 ). N) significant ditlerence in monocte TI expressioni was found betwccn paitients who were or were not taking aspirin.
In the group w-ith unstable angina. monocv}-te TF expression w-as positivels correlated w-ith the time fromn the onset of the last episode of pain (r=.64 and .61. 1P<.00(13) for cells incubaited xxithout and with endotoxin. respectivclx (Fig 3) . In the group with mvocardial infarction. nio such correlation xwas found. As the time fronm oinset of symptoms diftered between the mvocardial intarction and the unstable angina group. levels of monocste PCA were compared betw.cen the two groups for patients admitted in the first 1(0 hours after the onset of pain. In these subgroups. monocyte PCA was again significantls higher in the unstable angina group than in the mnocardial infarction group P=..0001).
Coagulation Parameters
The lexels of fibrinogen and of Fl1--2 are presented in were shown to have a vasoconstrictor substance in coronary sinus blood, whose vasoconstrictor effects in vitro were inhibited by a serotonin antagonist.17 Clinical studies provide additional evidence for the importance of platelet aggregation in the pathogenesis of unstable angina. Aspirin, an inhibitor of cyclooxygenase, of thromboxane, and of platelet aggregation, reduces the incidence of nonfatal myocardial infarction and of sudden death in patients with unstable angina.18 '19 Role of Inflammation Recent data suggest that inflammation may also play an important role in the pathophysiology of unstable angina. Berk et The design of the study did not allow us to determine whether the increase in markers of inflammation in unstable angina was a cause or a consequence of plaque instability. The increase in systemic markers of inflammation may simply be a reflection of events occurring in the coronary circulation. However, although the clinical manifestations of unstable angina are determined by its effects at the level of the coronary circulation, the demonstration of a systemic inflammatory response in such patients supports the intriguing possibility that systemic factors may, in some circumstances, contribute to plaque instability.
Conclusions
The results of the present study suggest that a timedependent inflammatory process occurs in at least some patients with unstable angina and demonstrate that evidence for such an inflammatory response is detectable in the systemic circulation. Further studies are needed to determine the factors that initiate and sustain leukocyte activation in unstable angina and to determine the relative contribution of platelet and leukocyte activation in the genesis of plaque instability.
